Park Ha Biological Technology Co Ltd (NASDAQ:PHH) price on Wednesday, July 02, rose 9.28% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $39.8.
A look at the stock’s price movement, the close in the last trading session was $36.42, moving within a range at $36.5 and $39.97. The PE ratio in trailing twelve months stood at 687.39. Turning to its 52-week performance, $36.92 and $3.70 were the 52-week high and 52-week low respectively. Overall, PHH moved 176.01% over the past month.
Park Ha Biological Technology Co Ltd’s market cap currently stands at around $1.05 billion, with investors looking forward to this quarter’s earnings report slated for in August.
PHH’s current price about 55.79% and 112.92% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 92.56, while 7-day volatility ratio is 5.25% and 10.66% in the 30-day chart. Further, Park Ha Biological Technology Co Ltd (PHH) has a beta value of 0.
If we refocus on Park Ha Biological Technology Co Ltd (NASDAQ:PHH), historical trading data shows that trading volumes averaged 1.04 over the past 10 days and 458.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 25.00 million shares.
The 81.71% of Park Ha Biological Technology Co Ltd’s shares are in the hands of company insiders while institutional holders own 0.19% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 58992.0 on 2025-06-13, giving us a short ratio of 0.17. The data shows that as of 2025-06-13 short interest in Park Ha Biological Technology Co Ltd (PHH) stood at 81.0 of shares outstanding, with shares short falling to 74261.0 registered in 2025-05-15. It is this reason that could see investor optimism for the PHH stock continues to rise going into the next quarter.
